Table 3.
Hypertension medication use and daily energy and sodium intake among women of child-bearing age by degree of blood pressure controla
| Self-reported hypertension | |||
|---|---|---|---|
| All (N = 824) | Controlled hypertensionb (N = 616) | Uncontrolled hypertensionb (N = 208) | |
| US population | 4,456,603 | 3,450,250 | 1,006,353 |
| Age (year) | 37.9 (0.3) | 37.5 (0.36) | 39.6 (0.52)† |
| Taking prescription for hypertension | 84.8 | 87.2 | 77.8† |
| Beta-blocker | 14.4 | 14.5 | 14.4 |
| Atenololc | 4.85 | 4.87 | 4.80 |
| Labetalol | 0.85 | 0.97 | 0.48† |
| Diuretic | 25.0 | 25.6 | 23.1 |
| ACE inhibitor/ARBc | 33.6 | 35.5 | 27.9† |
| Calcium-channel blockers | 11.3 | 10.9 | 12.5 |
| Nifedipine | 1.45 | 1.62 | 0.96 |
| Methyldopa | 0.48 | 0.49 | 0.48 |
| Mineralocorticoid receptor antagonistsc | 1.09 | 1.29 | 0.48† |
| Multidrug (≥ 2 drug classes) | 24.5 | 25.0 | 23.1 |
| Energy intake (kcal) | 1,916 (29) | 1,931 (35) | 1,862 (46) |
| Sodium intake (mg/1,000 kcal) | 1,692 (22) | 1,704 (26) | 1,653 (39) |
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; Beta-blocker, beta-adrenergic blocking agents; DBP, diastolic blood pressure; SBP, systolic blood pressure.
aData are reported as mean percentage of subjects or mean (SE) number of indicated units.
bControlled hypertension defined by SBP <140 mm Hg and DBP <90 mm Hg. Uncontrolled hypertension defined by SBP ≥140 mm Hg or DBP ≥90 mm Hg.
cMedications not recommended in pregnancy.
† P < 0.05.